CLINICAL TRIAL: INVESTIGATE THE EFFICACY & SAFETY OF PURIFIED C1 ESTERASE INHIBI
CLINICAL TRIAL: INVESTIGATE THE EFFICACY & SAFETY OF PURIFIED C1 ESTERASE INHIBI
批准号:
7724937
负责人:
Bruce L. Zuraw
金额:
$0.23万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-01 至 2008-11-30
中文摘要
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
确定与安慰剂相比,接受C1INH-nf治疗的受试者缓解决定性症状的中位时间是否更短。测试与安慰剂相比,接受C1INH-nr治疗的受试者的缓解时间是否不同。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Determine whether C1INH-nf treated subjects have shorter median time to relief of the defining symptoms compared to placebo. Test whether time to relief is different in subjects treated with C1INH-nr compared to placebo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms Underlying the Dominant Negative Phenotype in Hereditary Angioedema
-
批准号:10412915
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Bruce L. Zuraw
-
依托单位:
Mechanisms Underlying the Dominant Negative Phenotype in Hereditary Angioedema
-
批准号:10516092
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Bruce L. Zuraw
-
依托单位:
Mechanisms Underlying the Dominant Negative Phenotype in Hereditary Angioedema
-
批准号:10044412
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Bruce L. Zuraw
-
依托单位:
Dual role of the bradykinin B2 receptor during inflammation
-
批准号:7929357
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Bruce L. Zuraw
-
依托单位:
Dual role of the bradykinin B2 receptor during inflammation
-
批准号:8196318
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Bruce L. Zuraw
-
依托单位:
Dual role of the bradykinin B2 receptor during inflammation
-
批准号:8391112
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Bruce L. Zuraw
-
依托单位:
CLINICAL TRIAL: PHASE II STUDY OF THE SAFETY & EFFICACY OF RECOMBINANT HUMAN C1
-
批准号:8166834
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2009
-
负责人:Bruce L. Zuraw
-
依托单位:
CLINICAL TRIAL: PHASE II STUDY OF THE SAFETY & EFFICACY OF RECOMBINANT HUMAN C1
-
批准号:7950979
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2008
-
负责人:Bruce L. Zuraw
-
依托单位:
CLINICAL TRIAL: PHARMACOKINETICS OF C1INH-NF IN HEREDITARY ANGIOEDEMA SUBJECTS
-
批准号:7724962
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2007
-
负责人:Bruce L. Zuraw
-
依托单位:
CLINICAL TRIAL: PHASE II STUDY OF THE SAFETY & EFFICACY OF RECOMBINANT HUMAN C1
-
批准号:7724969
-
项目类别:
-
资助金额:$0.32万
-
财政年份:2007
-
负责人:Bruce L. Zuraw
-
依托单位:
Epithelial GILZ in Inflammation and Remodeling
-
批准号:8330064
-
项目类别:
-
资助金额:$36.83万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
INVESTIGATE THE EFFICACY & SAFETY OF PURIFIED C1 ESTERASE INHIBITOR FOR HAE
-
批准号:7606584
-
项目类别:
-
资助金额:$1.01万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
Epithelial GILZ in Inflammation and Remodeling
-
批准号:8711195
-
项目类别:
-
资助金额:$35.87万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
Epithelial GILZ in Inflammation and Remodeling
-
批准号:8897958
-
项目类别:
-
资助金额:$35.01万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
Mechanisms and control of epithelial to mesenchymal transition in chronic asthma
-
批准号:7150800
-
项目类别:
-
资助金额:$26.18万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
Epithelial GILZ in Inflammation and Remodeling
-
批准号:8516971
-
项目类别:
-
资助金额:$35.57万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
Epithelial GILZ in Inflammation and Remodeling
-
批准号:8381195
-
项目类别:
-
资助金额:$35.42万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
GILZ Controls TLR-Induced NF-kB Activity In Acute Asthma
-
批准号:6922726
-
项目类别:
-
资助金额:$41.98万
-
财政年份:2005
-
负责人:Bruce L. Zuraw
-
依托单位:
GILZ Controls TLR-Induced NF-kB Activity In Acute Asthma
-
批准号:7086290
-
项目类别:
-
资助金额:$47.14万
-
财政年份:2005
-
负责人:Bruce L. Zuraw
-
依托单位:
GILZ Controls TLR-Induced NF-kB Activity In Acute Asthma
-
批准号:7390687
-
项目类别:
-
资助金额:$43.26万
-
财政年份:2005
-
负责人:Bruce L. Zuraw
-
依托单位:
海外基金